Tuberculosis Cases and Deaths Averted by PEPFAR

24 Mar 20264 min read0 viewsJournal Feed

GIST

New England Journal of Medicine, Volume 394, Issue 16 , Page 1655-1656, April 23, 2026.

Clinical Editorial

Summary

New England Journal of Medicine published a clinical update in Research Highlights on 24 Mar 2026. The item focuses on Tuberculosis Cases and Deaths Averted by PEPFAR. Open the detail page to review the full original feed content.

Source Reference

Read the full original publication from the source journal or publisher link below.

Open Original Source More Feed Items

Related by Condition/Drug

Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993–2025: A systematic review and meta-analysis

Research Highlights • 22 May 2026

Association of community sociodemographic and tuberculosis-related factors with variability in community-level tuberculosis stigma in South Africa: an ecological analysis from the MISSED TB Outcomes study

Research Highlights • 21 May 2026

Performance of active drug safety monitoring and management for pharmacovigilance strengthening in Ethiopia, experience from a multidrug-resistant tuberculosis management program: a cross-sectional study

Research Highlights • 20 May 2026

Shared autonomous HERV loci transcription identifies a unique circulating CD14+-xCR1+ mononuclear cell phenotype in a patient group with post-acute sequelae of COVID-19

Research Highlights • 19 May 2026

A Danish Couple’s Maverick African Research Finds Its Moment in RFK Jr.’s Vaccine Policy

Research Highlights • 18 May 2026

Identification of risk areas and associated factors of unfavorable treatment outcomes in drug-resistant tuberculosis: Evidence from Rio de Janeiro, Brazil

Research Highlights • 08 May 2026

Feed Metadata

Source

New England Journal of Medicine